Levofloxacin Hemihydrate 250mg Capsules from Mexico
Capsules containing levofloxacin hemihydrate equivalent to 250mg base, for oral therapy of acute bacterial rhinosinusitis. HTS 3004.90.92.12 covers these as products with levofloxacin salts in retail measured doses for prophylactic/therapeutic use.
Duty Rate — Mexico → United States
100%
Rate breakdown
9903.04.60100%Pharmaceuticals Annex IV: patented pharma articles — 100% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Specify hydrate form in entry docs; test for water content per pharmacopeia
• Capsule shells must be declared non-GMO gelatin or vegetarian
• Monitor for tendon rupture warnings in labeling per FDA black box